Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Abbvie (ABBV) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 33 quarters since 2013. Compare with ABBV stock chart to see long term trends.

ABBV stock compared to

ABBV Income Statement

Revenue, Net:13010000000
Revenue Per Share:7.35
Cost of Goods & Services Sold:4213000000
Selling, General & Admin Expense:2842000000
Research & Development Expense:1782000000
Total Operating Expenses:8907000000
Operating Income:4103000000
Income Taxes:312000000
Net Income:3555000000
Earnings Per Share, Basic:2
Shares Outstanding, Basic Avg:1769000000

ABBV Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:866000000
Net Cash from Operations:4877000000
Repurchases/Buybacks Common Stock:787000000
Cash Dividends Paid:2322000000
Net Cash from Financing Activities:-3174000000
Property, Plant & Equipment Purchases:188000000
Net Cash from Investing Activities:-342000000
Net Change in Cash & Equivalents:1306000000

ABBV Balance Sheet

Cash and Cash Equivalents:9755000000
Short-Term Investments:22000000
Accounts Receivable, Net:9588000000
Inventories:3272000000
Total Current Assets:26569000000
Property, Plant & Equipment, Net:5193000000
Total Assets:150501000000
Accounts Payable:null
Total Short-Term Liabilities:31951000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
144,334,850 sh
-3,051,958 sh
-2%
$12,642,290
-$1,828,148
Blackrock Inc.
122,016,637 sh
-1,339,787 sh
-1%
$10,687,437
-$1,423,696
Price T Rowe Associates Inc /Md/
32,739,879 sh
-9,038,901 sh
-22%
$2,867,686
-$1,234,155
FMR LLC
30,257,179 sh
-1,112,935 sh
-4%
$2,650,227
-$429,692
Northern Trust Corp
24,363,192 sh
210,056 sh
1%
$2,133,971
-$237,384
Berkshire Hathaway Inc
21,264,316 sh
21,264,316 sh
NEW
$1,862,541
$1,862,541
Bank Of America Corp /De/
18,207,656 sh
18,073,956 sh
13518%
$1,594,807
$1,581,680
Morgan Stanley
13,731,455 sh
1,296,673 sh
10%
$1,202,737
-$18,108
Renaissance Technologies LLC
13,470,803 sh
-5,551,066 sh
-29%
$1,179,908
-$687,659
Legal & General Group Plc
10,828,443 sh
-319,749 sh
-3%
$948,462
-$145,995
Royal Bank Of Canada
10,595,638 sh
10,310,338 sh
3614%
$928,073
$900,062
Goldman Sachs Group Inc
10,099,312 sh
9,847,812 sh
3916%
$884,598
$859,906
UBS Asset Management Americas Inc
9,175,157 sh
426,045 sh
5%
$803,652,002
-$55,335,815
Charles Schwab Investment Management Inc
8,128,713 sh
-329,940 sh
-4%
$711,994
-$118,477
Ameriprise Financial Inc
7,968,311 sh
-62,686 sh
-1%
$696,731
-$91,954
Amundi Pioneer Asset Management Inc
4,987,894 sh
-55,863 sh
-1%
$436,814
-$58,350
Credit Suisse Ag/
4,622,072 sh
3,685,072 sh
393%
$404,848
$312,853
Voya Investment Management LLC
4,568,473 sh
44,945 sh
1%
$400,152
-$43,968
Farallon Capital Management LLC
4,250,000 sh
100,000 sh
2%
$372,258
-$35,189
Invesco Ltd.
3,985,730 sh
532,295 sh
15%
$349,109
$10,049

Data imported from Abbvie Inc SEC filings. Check original filings before making any investment decision.